Long-Term Prognosis for 1-Year Relapse-Free Survivors of CD34+ Cell-Selected Allogeneic Hematopoietic Stem Cell Transplantation: A Landmark Analysis

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2017.197

Related search